BPC
XBI icon

Banque Pictet & Cie’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Banque Pictet & Cie’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-35,000
Closed -$2.07M – 367
2016
Q4 		$2.07M Buy
35,000
+7,200
+26% +$444K 0.05% 181
2016
Q3 		$1.84M Buy
+27,800
New +$1.72M 0.05% 179

Other funds holding XBI

MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
RAM
Riggs Asset Management Dallas, Pennsylvania $560M AUM 64.94% 1-Year Est. Return

Banque Pictet & Cie's XBI Position: Q2 2026 in Review

Banque Pictet & Cie reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 16% in Q2 2026, selling an estimated $1.41M and leaving 53,821 shares worth $8.52M. The position accounts for 0.05% of the portfolio, ranked #115.

Banque Pictet & Cie first reported a position in XBI in Q1 2014 and has held it in 43 quarters since. The position peaked at $15.4M in Q1 2017. 359 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Banque Pictet & Cie held 53,821 shares of State Street SPDR S&P Biotech ETF worth $8.52M as of Q2 2026.
  • Banque Pictet & Cie sold 10,396 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.41M.
  • State Street SPDR S&P Biotech ETF made up 0.05% of Banque Pictet & Cie's portfolio in Q2 2026, its #115 holding.
  • Banque Pictet & Cie first reported a position in State Street SPDR S&P Biotech ETF in Q1 2014 and has held it in 43 quarters since.
  • Banque Pictet & Cie's State Street SPDR S&P Biotech ETF position peaked at $15.4M in Q1 2017.
  • 359 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.